Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-11-16Immunisation Status Against Major Communicable Diseases Preventable With Vaccines, and Safety of Vaccines, in a Cohort of MS Patients. An Italian Multicenter Study
-
CLINICAL_TRIALS study record update · 2022-11-15Taxonomy of Neurorehabilitation Treatments and Outcome Measures: a Multicentre Italian Study
-
CLINICAL_TRIALS study record update · 2022-11-15The Effect of Different Electrical Stimulations on Pain, Functional Capacity and Quality of Life in Multiple Sclerosis Patients
-
CLINICAL_TRIALS study record update · 2022-11-15Behaviour and Well-Being: A Bio-Psycho-Social Model of Resilience in Young Adults Newly Diagnosed With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-11-14MS and NMOSD in African-Americans: a Prospective Data Collection Protocol Using REDCap
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-11-14Utility of Quantification of Afferent Pupillary Defect in Predicting Optic Nerve Disease in Retrobulbar Neuritis, Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease - a Retrospective and Prospective Analysis
-
CLINICAL_TRIALS study record update · 2022-11-08Risk Perception in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-11-08Characterization of Early Patients Initiating Ofatumumab for Treatment of Multiple Sclerosis in the Real-World
-
CLINICAL_TRIALS study record update · 2022-11-04The Acute Optic Neuritis Network (ACON): a Non-interventional Prospective Multicenter Study on Diagnosis and Treatment of Acute Optic Neuritis
-
CLINICAL_TRIALS study record update · 2022-11-03Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients With and Without Ocrelizumab Treatment, and Comparing Immune Responses to COVID-19 in MS Patients on Ocrelizumab and Healthy Controls
-
CLINICAL_TRIALS study record update · 2022-11-03Exercise as a Supplemental Treatment Strategy Early in the Disease Course of Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-10-28Identification of New Biomarkers Useful to Define the Course of Multiple Sclerosis and Study of the Mechanisms That Promote Synaptic Damage
-
CLINICAL_TRIALS study record update · 2022-10-25Hybrid PET/MR Imaging to Assess Demyelination and Axonal Injury in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-10-25Fecal Microbial Transplantation for Relapsing Multiple Sclerosis Patients - a Placebo-controlled, Double-blinded, Randomized Trial
-
CLINICAL_TRIALS study record update · 2022-10-21Validity and Reliability of the Turkish Version of F-2-MS Scale
-
CLINICAL_TRIALS study record update · 2022-10-20MAIN STUDY: Switching Relapsing Multiple Sclerosis Patients Treated With Natalizumab at Risk for Progressive Multifocal Leukoencephalopathy to Teriflunomide: Is This Safe and Effective? SUB-STUDY: Analysis of JCV Antibody Index in MS Patients Treated With Teriflunomide
-
CLINICAL_TRIALS study record update · 2022-10-20Feasibility of Low-load Resistance Training Using Blood Flow Restriction for People With Multiple Sclerosis and Marked Mobility Restriction
-
CLINICAL_TRIALS study record update · 2022-10-20Exploring the Effects of B Cell Depletion With Ofatumumab on Immune Cells and Meningeal Lymphatic Drainage in Patients With Demyelinating Diseases - a Prospective Observational Study
-
CLINICAL_TRIALS study record update · 2022-10-19Optimal Diagnostic Algorithm for Neurogenic Lower Urinary Tract Symptoms in Patients With MS
-
CLINICAL_TRIALS study record update · 2022-10-18A Phase III, Randomized, Two-armed, Double-blind, Parallel, Active-controlled Clinical Trial to Evaluate Equivalency of the Efficacy and Safety of Ocrelizumab (CinnaGen, Iran) in Comparison to Reference Product, Ocrevus® (Roche, Switzerland) in Patients With Relapsing Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-10-14Thematic Studies of Multiple Sclerosis and Related Diseases
-
CLINICAL_TRIALS study record update · 2022-10-14Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis Patients
-
CLINICAL_TRIALS study record update · 2022-10-14Reinventing Yourself With Multiple Sclerosis (MS): An Intervention Aimed at Improving Self-Efficacy, Coping, Psychological Well-being, and Quality of Life in MS
-
CLINICAL_TRIALS study record update · 2022-10-12Combined Neurofilament Light Chain ,Chitinase-3 Like-1 Protein Levels and Tolerogenic Plasmacytoid Dendritic Cells in Defining Disease Course in Multiple Sclerosis Patients
-
CLINICAL_TRIALS study record update · 2022-10-10The Reliability and Validity of the Figure of 8 Walk Test in Multiple Sclerosis